Search
Marker Therapeutics Inc
MRKRAdd to Watchlist
1.220USD
-0.050-3.94%
Close 07-24 16:00（ET）Quotes delayed by 15 min
20.34MMarket Cap
LossP/E TTM
MRKR Financials
See Marker Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Marker Therapeutics Inc Earnings Date
Latest Release
May 15, 2026
EPS / Forecast
-0.16/-0.18
Revenue / Forecast
751.69K/682.00K
Period
FY2025 Earnings
Revenue(YoY)
3.55M
-46.19%
EPS(YoY)
-0.79
33.52%
Analyst Rating
BUY
2026/07/26
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its total revenue reached 3.55M, with a year-on-year change of 6.59M.
What are the current assets of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its current assets were 19.07M, with a year-on-year change of -13.40.
What are the total assets of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its total assets of Marker Therapeutics Inc were 19.07M, with a year-on-year change of -13.40.
What are the total liabilities of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its total liabilities of Marker Therapeutics Inc were 2.27M, with a year-on-year change of -34.36.
What is the total equity of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its total equity of Marker Therapeutics Inc was 16.80M, with a year-on-year change of -9.49.
What is the net operating income of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its net operating income of Marker Therapeutics Inc was -12.44M, with a year-on-year change of -11.86.
What is the net financing of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its net financing of Marker Therapeutics Inc was 9.86M, with a year-on-year change of -34.20.
What is the Earnings Per Share (EPS) of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.79, with a year-on-year change of 33.52.
What is the net income of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its net income was -12.16M, with a year-on-year change of -13.35.
What is the net margin of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its net profit margin was -342.96, with a year-on-year change of -110.64.
What is the Return on Equity (ROE) of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -68.81, with a year-on-year change of -4.55.
What is the Return on Assets (ROA) of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -59.20, with a year-on-year change of -7.99.
What is the operating profit of Marker Therapeutics Inc?
According to Marker Therapeutics Inc's FY2025 earnings report, its operating profit was -12.44M, with a year-on-year change of -11.86.